|
It was reported that during intar aortic balloon(iab) therapy a restriction alarm was received on a cardiosave prior shift.The patient was taken to the cardiac cath lab for iab exchange where under imaging, the radiopaque markers appeared to be close together, near the middle of the catheter.No patient injury or harm was reported.
|
|
Updated fields: b4, d8, g1, g3, g6, h2, h6 (type of investigation, investigation findings, investigation conclusion), h11.No decon or visual inspection performed since product was not returned and could not be evaluated.Therefore, we were unable to confirm or determine a root cause for the reported failure.The failure mode is addressed in the risk file and is operating within its risk profile.The ifu addresses the reported failure.There were no ncmrs identified which could cause or contribute to the reported failure.The investigation does not indicate that the device was inadvertently released as non-conforming or an adulterated product or was a counterfeit.The complaint history review did not identify an adverse trend (increase in number of complaints over past three (3) months).Based on the rational provided above, no escalation to the capa process is required.
|